Updates Royalty Pharma: Business Model May Be Over-Sold, But Shares Are Undervalued & Could Trade >$80 by Kourosh MaheriNovember 27, 2020 Kourosh Maheri See author's posts Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Like this:Like Loading... Related